Plexera Biosciences Announces ISO Certification
Lumera zu myNews hinzufügen Was ist das?
Plexera Biosciences LLC, a wholly owned subsidiary of Lumera Corporation
(NASDAQ:LMRA), announced today that it has been awarded a Certificate of
Registration for operating a quality management system that complies
with ISO 9001:2000 requirements.
This registration certifies that the policies, practices, and procedures
of Plexera Bioscience follow industry-respected best practices for
consistently designing and manufacturing quality products with the goal
of total customer satisfaction. To become certified, Plexera Bioscience
underwent a stringent evaluation process which ended with a multi-day
independent audit of its entire Quality Management System (QMS),
including extensive document review and employee interviews to confirm
compliance.
"Achieving ISO certification demonstrates our
commitment to providing quality, innovative life science products, which
is critical to customer satisfaction and the success of our company,”
said Dr. Tim Londergan, President and Chief Operating Officer. "It
is a critical component of our continuous efforts to develop and
commercialize new products based on our Kx Array™
Technology.” Kx Array™ technology combines
label-free biosensor technology with microarray based assay formats to
provide a fully integrated, easy-to-use platform for analyzing thousands
of biomolecular interactions in a single experiment. Compared to
traditional arrays that only provide qualitative end-point data, Kx
Array technology monitors reactions in real-time enabling multiplexed
quantitative analysis of absolute and relative specificities,
affinities, and concentrations.
About Plexera Biosciences LLC
Plexera Biosciences LLC., a wholly owned subsidiary of Lumera
Corporation (NASDAQ:LMRA), develops and manufactures advanced analytical
tools and methods that enable life science researchers to probe the
human proteome for improved diagnostics, therapeutics, and knowledge of
the human condition. For more information, please visit www.plexera.com.
Certain statements contained in this release are forward-looking
statements that involve a number of risks and uncertainties. Factors
that could cause actual results to differ materially from those
projected in the company's forward-looking statements include the
following: market acceptance of our technologies and products; our
ability to obtain financing; our financial and technical resources
relative to those of our competitors; our ability to keep up with rapid
technological change; government regulation of our technologies; our
ability to enforce our intellectual property rights and protect our
proprietary technologies; the ability to obtain additional contract
awards and to develop partnership opportunities; the timing of
commercial product launches; the ability to achieve key technical
milestones in key products; and other risk factors identified from time
to time in the company's SEC reports, including its Annual Report on
Form 10-K, and its Quarterly Reports on Form 10-Q.
